These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8518221)

  • 1. Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
    Peltier P; Dutin JP; Chatal JF; Fumoleau P; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
    Ann Oncol; 1993 Apr; 4(4):307-11. PubMed ID: 8518221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlative imaging study in the diagnosis of ovarian cancer recurrences. The INSERM Research Network (Nantes, Rennes, Reims, Villejuif, Saclay), France.
    Peltier P; Wiharto K; Dutin JP; Chatal JF; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
    Eur J Nucl Med; 1992; 19(12):1006-10. PubMed ID: 1464352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
    Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R
    Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
    Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
    Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
    Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.
    Reinsberg J; Wagner U; Krebs D
    Arch Gynecol Obstet; 1994; 255(1):9-18. PubMed ID: 8042882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoscintigraphy of recurrences of gynecologic carcinomas.
    Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
    J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
    Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
    Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
    Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
    Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
    Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
    Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
    Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Schijf CP; Strijk SP; Poels LG; van Hoesel RG; Corstens FH
    J Nucl Med; 1990 Nov; 31(11):1802-10. PubMed ID: 2230993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
    Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
    Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoscintigraphy with 131I or 111In labelled OC 125 F(ab')2 fragments in patients with ovarian carcinoma.
    Jiménez-Vicioso A; Torres M; Jiménez-Heffernan A; Grana MD; Latre JM; Llamas JM; Carreras JL; Mateo A
    Int J Biol Markers; 1990; 5(4):159-65. PubMed ID: 2093731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
    Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
    J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody.
    Chung JK; Kang SB; Lee HP; Lee MC; Koh CS; Sakahara H; Endo K
    J Nucl Med; 1993 Oct; 34(10):1651-5. PubMed ID: 8410277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
    Vuillez JP; Peltier P; Mayer JC; Dubois F; Chetanneau A; Fumoleau P; Bertrand A; Chatal JF
    J Nucl Med; 1991 Feb; 32(2):221-7. PubMed ID: 1992023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancer.
    Hunter RE; Doherty P; Griffin TW; Gionet M; Hnatowich DJ; Bianco JA; Dillon MB
    Gynecol Oncol; 1987 Jul; 27(3):325-39. PubMed ID: 3497845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery.
    Risum S; Høgdall C; Markova E; Berthelsen AK; Loft A; Jensen F; Høgdall E; Roed H; Engelholm SA
    Int J Gynecol Cancer; 2009 May; 19(4):600-4. PubMed ID: 19509556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
    Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
    Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
    Sugiyama S
    Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.